Bicalutamide

Indication

Hormonal therapy for metastatic cancer

  • Bicalutamide (Casodex) 50 mg po qd


Drug Information

  • Generic Name: Bicalutamide
  • Trade Name: Casodex
  • Casodex is a hormone therapy. It is classified as an "anti-androgen." Often given in combination with "LHRH agonist," another type of hormone therapy.
  • Casodex therapy is for men with advanced prostate cancer at stage D2, when there is evidence of metastases (cancer spread) to other areas of the body.

References

Loblaw DA et al. Initial hormonal management of androgen-sensitive metastatic, recurrent, or progressive prostate cancer: 2006 update of an American Society of Clinical Oncology Practice Guideline. J Clin Oncol 2007; 25:1596